Professor Vasso Apostolopoulos is currently the Pro Vice-Chancellor, Research Partnerships at Victoria University.
She received her PhD majoring in immunology in 1995 from the University of Melbourne, and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Her expertise is multi-disciplinary with extensive expertise in immunology, x-ray crystallography, medicinal chemistry, cellular biology, molecular biology. She has extensive translational research expertise with development of drugs and vaccines. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognised with over 100 awards for the outstanding results of her research. Most notable are the Premier’s Award for Medical Research, Young Australian of the Year (Vic), Greek Australian of the Year, Woman of the Year. She was named as one of the most successful Greeks abroad by the prestigious Times magazine. Using immunotherapy, Vasso has also developed the world’s first ovarian cancer vaccine, which attracted the investment by a pharmaceutical company and has been commercialised in the Middle East. Committed to the wide-ranging benefits of immunotherapy, Vasso has applied this approach to other diseases including a vaccine for multiple sclerosis (which will undergo human clinical trials early in 2019). Vasso’s work has been awarded a research grant to develop a vaccine for type-1 diabetes.
Professor Vasso Apostolopoulos is currently the Pro Vice-Chancellor, Research Partnerships at Victoria University.
She received her PhD majoring in immunology in 1995 from the University of Melbourne, and the Advanced Certificate in Protein Crystallography from Birkbeck College, University of London. Her expertise is multi-disciplinary with extensive expertise in immunology, x-ray crystallography, medicinal chemistry, cellular biology, molecular biology. She has extensive translational research expertise with development of drugs and vaccines. Professor Vasso Apostolopoulos is a world-renowned researcher who has been recognised with over 100 awards for the outstanding results of her research. Most notable are the Premier’s Award for Medical Research, Young Australian of the Year (Vic), Greek Australian of the Year, Woman of the Year. She was named as one of the most successful Greeks abroad by the prestigious Times magazine. Using immunotherapy, Vasso has also developed the world’s first ovarian cancer vaccine, which attracted the investment by a pharmaceutical company and has been commercialised in the Middle East. Committed to the wide-ranging benefits of immunotherapy, Vasso has applied this approach to other diseases including a vaccine for multiple sclerosis (which will undergo human clinical trials early in 2019). Vasso’s work has been awarded a research grant to develop a vaccine for type-1 diabetes.